Basic Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Mar 28, 2019; 25(12): 1465-1477
Published online Mar 28, 2019. doi: 10.3748/wjg.v25.i12.1465
Figure 2
Figure 2 Estimation of clinical and morphological changes of dextran sulfate sodium-induced colitis. A: The four-point disease activity index (DAI) was evaluated scoring daily body weight of mice, the percentage of body weight loss, the trait of the stool and the presence of occult blood in feces. B: Body weight, one of the DAI parameter, is also represented separately by percentage, where the mice weight at 1st d of experiment is equal to 100%. C: Colon length is another parameter to evaluate the healthy or disease state of the mice: the mean values in the 4 groups at day 5 are shown. aP < 0.05; bP < 0.01; cP < 0.0001. DSS: Dextran sulfate sodium; TNFα: Tumor necrosis factor α; DAI: Disease activity index.

  • Citation: Petito V, Graziani C, Lopetuso LR, Fossati M, Battaglia A, Arena V, Scannone D, Quaranta G, Quagliariello A, Del Chierico F, Putignani L, Masucci L, Sanguinetti M, Sgambato A, Gasbarrini A, Scaldaferri F. Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis. World J Gastroenterol 2019; 25(12): 1465-1477
  • URL: https://www.wjgnet.com/1007-9327/full/v25/i12/1465.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v25.i12.1465